Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Oral tofacitinib successfully treated total body hair loss in one patient.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

Protein profiling of forehead skin can help distinguish between frontal fibrosing alopecia and androgenetic alopecia.

Somatostatin may help protect hair follicles from immune attacks.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

PPAR-γ is important for healthy hair and its problems, and more research on PPAR-γ treatments is needed.

Certain gene variations may increase the risk and severity of alopecia areata.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Activating Nrf2 in skin cells speeds up wound healing by increasing the growth of certain stem cells.

CGF therapy may effectively treat psoriasis by reducing inflammation.

The document concludes that dandruff and seborrheic dermatitis are linked to inflammation and skin changes, and treating them with specific shampoos can reduce these issues.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Hair loss in certain young mice is linked to a specific gene and can be caused by lack of iron.

The document concludes that products like PRP and PRF show promise for tissue healing, but evidence of their effectiveness is inconsistent.

Some plant-based chemicals may help with hair growth, but more research is needed to confirm their effectiveness.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Erdr1 could be a new marker for diagnosing hair loss.

COVID-19 can cause different skin issues, including rashes and hair loss.

Stress increases nerve fibers and immune cell activity in mouse skin, possibly worsening skin conditions.

BMP2 and BMP7 have opposite roles in feather formation.

Both mouse and rat models are effective for testing alopecia areata treatments.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.